Treatment With Pazopanib for Neoadjuvant Breast Cancer
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the treatment of a doxorubicin in
combination with cyclophosphamide followed by a combination of pazopanib in combination with
paclitaxel prior to surgery results in a pathological complete response in females with
breast cancer.